Groups’ expense on salary and employee benefit, audit fee, advisory fee, advertising and IR related to IPO in January 2019 has increased 13.91 Million Baht compare to the last year. tel:02-455-2888 บริษัท
Company believe the equal weight of both method is suitable when determine the value of the Transaction. 7. Expected benefit for the Company Since the electronics industry is gradually increased toward its
normal business transaction is justified and will benefit the Company. Such Connected Transaction is considered at arm’s length basis. This transaction was considered and reviewed by the Audit Committee. 5
meeting appointment letter to the committee not less than seven (7) days before the meeting except the case of urgent meeting to preserve company’s benefit, then, the meeting appointment will be sent to the
5.84 40.07 Total Equity 13.07 24.80 24.91 Total Revenue 12.01 11.98 5.91 Net Profit 8.89* 2.72 (0.11) Remark: *IGEN-ENERGY booked profit from debt discharge amounting 9.61 million. 8. Expected benefit to
change is considered a revision of the project for the post-retirement benefit program. And has the effect that the Group has a provision for long-term employee benefits of Bt80 million which will record
yet determined. 7. Expected benefit of the Transaction The Company believes the Transaction would enhance the Company and its subsidiary CCPT-KY in aspect of the followings; The Company will be able
Consideration Currently, the offering price of ordinary shares in the IPO is not yet determined. 7. Expected benefit of the Transaction The Company believes the Transaction would enhance the Company and its
% Administrative expenses 84.7 91.1 6.4 7.6% Change Administrative expenses comprised of employee benefit expenses, consulting fee, depreciation, public relation expenses and others. Administrative expenses for Q1
expenses 91.1 121.4 30.3 33.3% Change Administrative expenses comprised of employee benefit expenses, consulting fee, depreciation, public relation expenses and others. Administrative expenses for Q1/2023